Global Immune Repertoire Sequencing Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 105

Report ID: 2086

Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portrays as the antigen-specific information within lymphocytes and has become increasingly significant to understand body’s autoimmunity and healthy immunity. This also propose novel ways to tackle cancer and development of personalized medicine by understanding the genetic makeup of a person. Since the last two decades, the technical advancements in the high throughput sequencing techniques along with the development in the bioinformatics and statistical tools have made the immune repertoire sequencing to be analyzed at single sequence level. This technology has potential to explore for the novel infectious agents and also offers new approaches for vaccine or antibody development.
In 2018, the global Immune Repertoire Sequencing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Immune Repertoire Sequencing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immune Repertoire Sequencing development in United States, Europe and China.

The key players covered in this study
ArcherDX
Junom Therapeutics
Roche Holding
Illumina
ThermoFisher Scietific
Pacific Biosciences
CD Genomics
Atreca
Adaptive Biotechnologies

Market segment by Type, the product can be split into
Pyro-Sequencing
Dye-Terminating Sequencing
Semiconductor Sequencing
Others

Market segment by Application, split into
Biomarker Discovery
Infectious Diseases
Vaccine Development and Efficacy
Cancer Immunotherapy
Autoimmune Disease
Transplant Rejection and Tolerance
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Immune Repertoire Sequencing status, future forecast, growth opportunity, key market and key players.
To present the Immune Repertoire Sequencing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Immune Repertoire Sequencing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Immune Repertoire Sequencing Market Size Growth Rate by Type (2014-2025)
1.4.2 Pyro-Sequencing
1.4.3 Dye-Terminating Sequencing
1.4.4 Semiconductor Sequencing
1.4.5 Others
1.5 Market by Application
1.5.1 Global Immune Repertoire Sequencing Market Share by Application (2014-2025)
1.5.2 Biomarker Discovery
1.5.3 Infectious Diseases
1.5.4 Vaccine Development and Efficacy
1.5.5 Cancer Immunotherapy
1.5.6 Autoimmune Disease
1.5.7 Transplant Rejection and Tolerance
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Immune Repertoire Sequencing Market Size
2.2 Immune Repertoire Sequencing Growth Trends by Regions
2.2.1 Immune Repertoire Sequencing Market Size by Regions (2014-2025)
2.2.2 Immune Repertoire Sequencing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Immune Repertoire Sequencing Market Size by Manufacturers
3.1.1 Global Immune Repertoire Sequencing Revenue by Manufacturers (2014-2019)
3.1.2 Global Immune Repertoire Sequencing Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Immune Repertoire Sequencing Market Concentration Ratio (CR5 and HHI)
3.2 Immune Repertoire Sequencing Key Players Head office and Area Served
3.3 Key Players Immune Repertoire Sequencing Product/Solution/Service
3.4 Date of Enter into Immune Repertoire Sequencing Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Immune Repertoire Sequencing Market Size by Type (2014-2019)
4.2 Global Immune Repertoire Sequencing Market Size by Application (2014-2019)

5 United States
5.1 United States Immune Repertoire Sequencing Market Size (2014-2019)
5.2 Immune Repertoire Sequencing Key Players in United States
5.3 United States Immune Repertoire Sequencing Market Size by Type
5.4 United States Immune Repertoire Sequencing Market Size by Application

6 Europe
6.1 Europe Immune Repertoire Sequencing Market Size (2014-2019)
6.2 Immune Repertoire Sequencing Key Players in Europe
6.3 Europe Immune Repertoire Sequencing Market Size by Type
6.4 Europe Immune Repertoire Sequencing Market Size by Application

7 China
7.1 China Immune Repertoire Sequencing Market Size (2014-2019)
7.2 Immune Repertoire Sequencing Key Players in China
7.3 China Immune Repertoire Sequencing Market Size by Type
7.4 China Immune Repertoire Sequencing Market Size by Application

8 Japan
8.1 Japan Immune Repertoire Sequencing Market Size (2014-2019)
8.2 Immune Repertoire Sequencing Key Players in Japan
8.3 Japan Immune Repertoire Sequencing Market Size by Type
8.4 Japan Immune Repertoire Sequencing Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Immune Repertoire Sequencing Market Size (2014-2019)
9.2 Immune Repertoire Sequencing Key Players in Southeast Asia
9.3 Southeast Asia Immune Repertoire Sequencing Market Size by Type
9.4 Southeast Asia Immune Repertoire Sequencing Market Size by Application

10 India
10.1 India Immune Repertoire Sequencing Market Size (2014-2019)
10.2 Immune Repertoire Sequencing Key Players in India
10.3 India Immune Repertoire Sequencing Market Size by Type
10.4 India Immune Repertoire Sequencing Market Size by Application

11 Central & South America
11.1 Central & South America Immune Repertoire Sequencing Market Size (2014-2019)
11.2 Immune Repertoire Sequencing Key Players in Central & South America
11.3 Central & South America Immune Repertoire Sequencing Market Size by Type
11.4 Central & South America Immune Repertoire Sequencing Market Size by Application

12 International Players Profiles
12.1 ArcherDX
12.1.1 ArcherDX Company Details
12.1.2 Company Description and Business Overview
12.1.3 Immune Repertoire Sequencing Introduction
12.1.4 ArcherDX Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.1.5 ArcherDX Recent Development
12.2 Junom Therapeutics
12.2.1 Junom Therapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Immune Repertoire Sequencing Introduction
12.2.4 Junom Therapeutics Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.2.5 Junom Therapeutics Recent Development
12.3 Roche Holding
12.3.1 Roche Holding Company Details
12.3.2 Company Description and Business Overview
12.3.3 Immune Repertoire Sequencing Introduction
12.3.4 Roche Holding Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.3.5 Roche Holding Recent Development
12.4 Illumina
12.4.1 Illumina Company Details
12.4.2 Company Description and Business Overview
12.4.3 Immune Repertoire Sequencing Introduction
12.4.4 Illumina Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.4.5 Illumina Recent Development
12.5 ThermoFisher Scietific
12.5.1 ThermoFisher Scietific Company Details
12.5.2 Company Description and Business Overview
12.5.3 Immune Repertoire Sequencing Introduction
12.5.4 ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.5.5 ThermoFisher Scietific Recent Development
12.6 Pacific Biosciences
12.6.1 Pacific Biosciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 Immune Repertoire Sequencing Introduction
12.6.4 Pacific Biosciences Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.6.5 Pacific Biosciences Recent Development
12.7 CD Genomics
12.7.1 CD Genomics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Immune Repertoire Sequencing Introduction
12.7.4 CD Genomics Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.7.5 CD Genomics Recent Development
12.8 Atreca
12.8.1 Atreca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Immune Repertoire Sequencing Introduction
12.8.4 Atreca Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.8.5 Atreca Recent Development
12.9 Adaptive Biotechnologies
12.9.1 Adaptive Biotechnologies Company Details
12.9.2 Company Description and Business Overview
12.9.3 Immune Repertoire Sequencing Introduction
12.9.4 Adaptive Biotechnologies Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.9.5 Adaptive Biotechnologies Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details